WPRIM Management System> DCMS> Asian Journal of Andrology> > 21> 1

Volume: 21 Issue: 1

1. Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer Page:12—18
2. Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians Page:19—23
3. Circulating tumor cells and their role in prostate cancer Page:24—31
4. Radical prostatectomy in patients aged 75 years or older: Review of the literature Page:32—36
5. Focal therapy for localized prostate cancer: Is there a 'middle ground' between active surveillance and definitive treatment? Page:37—44
6. PSA screening-for whom and when? Page:3—5
7. Hypogonadism is independently associated with varicocele repair in a contemporary cohort of men in the USA Page:45—49
8. Sperm fine-needle aspiration (FNA) mapping after failed microdissection testicular sperm extraction (TESE): Location and patterns of found sperm Page:50—55
9. Pretreatment serum albumin/globulin ratio as a prognostic biomarker in metastatic prostate cancer patients treated with maximal androgen blockade Page:56—61
10. Mean platelet volume might be an effective indicator of arterial erectile dysfunction Page:62—66
11. The role of vasoepididymostomy for treatment of obstructive azoospermia in the era of in vitro fertilization: A systematic review and meta-Analysis Page:67—73
12. Current and emerging trends in prostate cancer immunotherapy Page:6—11
13. G protein-coupled receptor kinase 2 inhibition improves erectile function through amelioration of endothelial dysfunction and oxidative stress in a rat model of type 2 diabetes Page:74—79
14. Lycopene exerts anti-inflammatory effect to inhibit prostate cancer progression Page:80—85
15. Sodium nitrite-derived nitric oxide protects rat testes against ischemia/reperfusion injury Page:92—97
16. Implementation of length expanding inflatable penile prosthesis is not sufficient to prevent postsurgical penile shortening Page:98—100
17. Pretreatment serum albumin/globulin ratio as a prognostic biomarker in metastatic prostate cancer patients treated with maximal androgen blockade. Page:56—61
18. The role of vasoepididymostomy for treatment of obstructive azoospermia in the era of in vitro fertilization: a systematic review and meta-analysis. Page:67—73
19. A constitutional jumping translocation involving the Y and acrocentric chromosomes. Page:101—103
20. Focal therapy for localized prostate cancer: is there a "middle ground" between active surveillance and definitive treatment? Page:37—44
21. Sperm fine-needle aspiration (FNA) mapping after failed microdissection testicular sperm extraction (TESE): location and patterns of found sperm. Page:50—55
22. Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia? Page:86—91
23. Time trend and characteristics of prostate cancer diagnosed in Hong Kong (China) in the past two decades. Page:104—106
24. Lycopene exerts anti-inflammatory effect to inhibit prostate cancer progression. Page:80—85
25. Mean platelet volume might be an effective indicator of arterial erectile dysfunction. Page:62—66
26. G protein-coupled receptor kinase 2 inhibition improves erectile function through amelioration of endothelial dysfunction and oxidative stress in a rat model of type 2 diabetes. Page:74—79
27. Implementation of length expanding inflatable penile prosthesis is not sufficient to prevent postsurgical penile shortening. Page:98—100
28. Sodium nitrite-derived nitric oxide protects rat testes against ischemia/reperfusion injury. Page:92—97
29. Hypogonadism is independently associated with varicocele repair in a contemporary cohort of men in the USA. Page:45—49
30. The 14th international prostate forum. Page:1—2